Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Olanzapine injection to be discontinued in UK Olanzapine injection, powder for reconstitution 5mg/mL, 10mg vial (Zyprexa; Lilly), is to be discontinued in theUK31st August 2012, for sales volume reasons. There is no generic or alternative […]
Category: Updates from www.palliativedrugs.com
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics FDA approve REMS for m/r opioids USFood and Drug administration (FDA) has approved a Risk Evaluation and Mitigation Strategy (REMS) program for all modified-release (m/r) opioids. Key components include prescriber training, updated patient information guides […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates NICE consultation on denosumab The National Institute for Health and Clinical Excellence (NICE) has issued a second appraisal consultation document on the use of denosumab as a treatment to delay or prevent skeletal-related events […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics BNF now available as a free smartphone app Health professionals can now access the British National Formulary (BNF) from a smartphone via a new application (app) from the National Institute for Health and Clinical […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Study published on the impact of co-proxamol withdrawal A time series study on the impact of co-proxamol withdrawal on prescribing and deaths in the UKhas been published. The study concludes that during the 6 […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics NICE issues clinical guideline on prescribing opioids in palliative care The UK National Institute for Health and Clinical Excellence (NICE) has issued a clinical guideline (CG140) on the safe and effective prescribing of strong […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com , the world’s leading palliative care website. Drug updates Tapentadol DTB review The Drug and Therapeutics Bulletin (DTB) has featured a review on the evidence for tapentadol (Palexia®, Grünenthal) for moderate to severe acute pain. The bulletin highlights some of the limitations of the […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates NPSA RRR: harm from flushing of nasogastric tubes before confirmation of placement The UK National Patient Safety Agency (NPSA) has issued a Rapid Response Repost (RRR) following the deaths of two patients since 10 […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics WHO guidelines for treating persistent pain in children The World Health Organization (WHO) has published a package on the pharmacological treatment of persisting pain in children with medical illnesses, which replaces the previous guidelines ‘Cancer […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates New generic buprenorphine sublingual tablets A branded generic of buprenorphine 200microgram and 400microgram sublingual tablets (Tephine®; Sandoz) has been launched in the UK. They are indicated as a strong analgesic for the relief of […]